A patient with MEN1 typical features and MEN2-like features.

IF 1.2 International Journal of Endocrine Oncology Pub Date : 2016-05-01 Epub Date: 2016-04-08 DOI:10.2217/ije-2015-0008
Diala El-Maouche, James Welch, Sunita K Agarwal, Lee S Weinstein, William F Simonds, Stephen J Marx
{"title":"A patient with MEN1 typical features and MEN2-like features.","authors":"Diala El-Maouche,&nbsp;James Welch,&nbsp;Sunita K Agarwal,&nbsp;Lee S Weinstein,&nbsp;William F Simonds,&nbsp;Stephen J Marx","doi":"10.2217/ije-2015-0008","DOIUrl":null,"url":null,"abstract":"<p><p>Multiple endocrine neoplasia (MEN) type 1 (MEN1) and 2 (MEN2) rarely co-exist in one case. Here we report a patient with features of both syndromes. The patient presented with typical MEN1 features plus pheochromocytoma and thickened corneal nerves. She had a germline 1132delG frameshift mutation in <i>MEN1</i>, no mutation in <i>CDKN1B</i> (<i>p27</i>) and no <i>RET</i> mutation, but had both <i>RET</i> polymorphisms Gly691Ser and Arg982Cys. This is the first case report of a combination of typical clinical findings of MEN1 harboring a germline <i>MEN1</i> mutation and the MEN2-like phenotype with negative full <i>RET</i> gene analysis of pathogenic variants. Possible explanations include a previously unrecognized phenotype-genotype association or the influence of potential phenotypic modifying <i>RET</i> variants. Furthermore, the combination observed in this patient may point to a single molecular pathway, and supports the possibility of as yet unrecognized connections between the molecular pathways for MEN1/menin protein and MEN2/RET protein.</p>","PeriodicalId":42691,"journal":{"name":"International Journal of Endocrine Oncology","volume":null,"pages":null},"PeriodicalIF":1.2000,"publicationDate":"2016-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2217/ije-2015-0008","citationCount":"6","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Endocrine Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2217/ije-2015-0008","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2016/4/8 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 6

Abstract

Multiple endocrine neoplasia (MEN) type 1 (MEN1) and 2 (MEN2) rarely co-exist in one case. Here we report a patient with features of both syndromes. The patient presented with typical MEN1 features plus pheochromocytoma and thickened corneal nerves. She had a germline 1132delG frameshift mutation in MEN1, no mutation in CDKN1B (p27) and no RET mutation, but had both RET polymorphisms Gly691Ser and Arg982Cys. This is the first case report of a combination of typical clinical findings of MEN1 harboring a germline MEN1 mutation and the MEN2-like phenotype with negative full RET gene analysis of pathogenic variants. Possible explanations include a previously unrecognized phenotype-genotype association or the influence of potential phenotypic modifying RET variants. Furthermore, the combination observed in this patient may point to a single molecular pathway, and supports the possibility of as yet unrecognized connections between the molecular pathways for MEN1/menin protein and MEN2/RET protein.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
患者具有MEN1典型特征和men2样特征。
多发性内分泌瘤(MEN) 1型(MEN1)和2型(MEN2)在同一病例中很少共存。在这里,我们报告一个具有两种综合征特征的患者。患者表现为典型的MEN1特征,并伴有嗜铬细胞瘤和角膜神经增厚。她在MEN1中有一个种系1132delG移码突变,CDKN1B (p27)没有突变,RET也没有突变,但RET多态性Gly691Ser和Arg982Cys都有。这是首次报道MEN1携带种系MEN1突变的典型临床表现和men2样表型与病原变异全RET基因分析阴性相结合的病例。可能的解释包括以前未被认识到的表型-基因型关联或潜在的表型修饰RET变异的影响。此外,在该患者中观察到的组合可能指向单一分子途径,并支持MEN1/menin蛋白和MEN2/RET蛋白分子途径之间尚未被识别的联系的可能性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
审稿时长
13 weeks
期刊介绍: International Journal of Endocrine Oncology is a quarterly, peer-reviewed journal that helps the clinician to keep up to date with best practice in this fast-moving field. The journal highlights significant advances in basic and translational research, and places them in context for future therapy. The journal presents the latest research findings in diagnosis and management of endocrine cancer, together with authoritative reviews, cutting-edge editorials and perspectives that highlight hot topics and controversy in the field. Independent drug evaluations assess newly approved medications and their role in clinical practice. The journal welcomes the unsolicited submission of article proposals and original research manuscripts.
期刊最新文献
Neoadjuvant use of lenvatinib in locally advanced papillary thyroid carcinoma involving critical vessels Recurrence-free survival following aggressive multimodal treatment of an isolated recurrence of adrenocortical carcinoma French patient-reported experience of diagnosis, management and burden of neuroendocrine tumors Bad kits in the diagnosis of endocrine tumors Somatotroph adenomas: histological subtypes and predicted response to treatment
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1